ACCESS Newswire·Oct 19, 2026, 9:30 AM ET

Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five Days

Cosmos Health expects U.S. Q4 2026 revenue to reach approximately $15 million & gross profit to reach approximately $10.5 million at a 70% gross margin.
Subscription revenue is projected to account for approximately $11.5 million of the total, comprised of $8.2 million from first orders & $3.3 million from renewals.
One-time purchases are expected to contribute the remaining approximately $3.5 million to total Q4 U.S. revenue.
As of October 19, 2026, the company tracked 14,624 online checkout orders, representing a 34% increase from the 10,881 reported on October 14, 2026.
Active U.S. subscriptions reached 8,940 as of October 19, 2026, a 42% rise from 6,287 announced five days prior, with a year-end target of exceeding 40,000 subscriptions.
Monthly subscription value at standard renewal pricing rose 44% to $1,325,338 as of October 19, 2026, compared to $919,945 on October 14, 2026.
The company anticipates daily U.S. sales to more than triple during the quarter, growing from $60,000 at the start to over $200,000 by year-end.
Subscription adoption at checkout has increased to 65.2% of all orders since inception, rising to over 85% of daily orders in recent days.
Key growth drivers include expanded marketing investment, digital customer acquisition, rising brand awareness, a broadening product offering, & strong subscription adoption at checkout.